Saqi A, Shaham D, Scognamiglio T, Murray M P, Henschke C I, Yankelevitz D, Vazquez M F
Department of Pathology, New York Presbyterian Hospital, Weill Cornell Medical Center, New York, USA.
Cytopathology. 2008 Jun;19(3):185-91. doi: 10.1111/j.1365-2303.2007.00439.x. Epub 2007 Mar 27.
Pulmonary hamartomas have a characteristic heterogeneous radiological appearance. However, when composed predominantly of undifferentiated mesenchymal fibromyxoid component, their homogeneous appearance on computed tomography is indeterminate for malignancy. Rendering an accurate preoperative diagnosis in these cases can alter management. The aim of this study was to determine the incidence and accuracy of cytodiagnosis for hamartomas 'indeterminate' by imaging.
We retrospectively reviewed records for hamartomas diagnosed by transthoracic fine needle aspiration (FNA) including immediate impressions and final diagnoses. Cytological features evaluated included the presence of fibromyxoid stroma, bronchioloalveolar cell hyperplasia, fibroadipose tissue, cartilage and smooth muscle.
Eighteen (1.3%) hamartomas were identified from 1355 transthoracic FNAs. The immediate impression was hamartoma in 13 (72%), carcinoid in one (6%), mucinous bronchioloalveolar carcinoma in two (11%) and non-diagnostic in two (11%). The final diagnosis of hamartoma in cases diagnosed as carcinoid, mucinous bronchioloalaveolar carcinoma and non-diagnostic on immediate impression was rendered following assessment of all cytological material.
Overall, FNAs are highly reliable for diagnosing hamartomas even when composed principally of undifferentiated mesenchymal fibromyxoid stroma, especially with the aid of all available preparations including Diff-Quik smears, Papanicolaou smears, ThinPreps and cell block material.
肺错构瘤具有特征性的异质性放射学表现。然而,当主要由未分化的间充质纤维黏液样成分组成时,其在计算机断层扫描上的均匀表现对于恶性肿瘤的诊断并不明确。在这些病例中做出准确的术前诊断可改变治疗方案。本研究的目的是确定影像学表现“不明确”的错构瘤的细胞诊断发生率和准确性。
我们回顾性分析了经胸细针穿刺抽吸(FNA)诊断的错构瘤记录,包括即时诊断印象和最终诊断。评估的细胞学特征包括纤维黏液样基质、细支气管肺泡细胞增生、纤维脂肪组织、软骨和平滑肌的存在情况。
在1355例经胸FNA中识别出18例(1.3%)错构瘤。即时诊断印象为错构瘤的有13例(72%),类癌1例(6%),黏液性细支气管肺泡癌2例(11%),未明确诊断2例(11%)。在对所有细胞学材料进行评估后,对即时诊断为类癌、黏液性细支气管肺泡癌及未明确诊断的病例做出了错构瘤的最终诊断。
总体而言,即使错构瘤主要由未分化的间充质纤维黏液样基质组成,FNA对其诊断也高度可靠,特别是借助所有可用的制片方法,包括Diff-Quik涂片、巴氏涂片、ThinPrep制片及细胞块材料。